A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiset tiedot
Päätekijä:	Islam, Saidul
Muut tekijät:	Sharmin, Shahana
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2022
Aiheet:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Linkit:	http://hdl.handle.net/10361/17308

Samankaltaisia teoksia

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Tekijä: Karim, Azrin
Julkaistu: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Flora, Sanzida Alam
Julkaistu: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Tekijä: Meem, Manila
Julkaistu: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Tekijä: Alam, Tahera
Julkaistu: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
Tekijä: Ahmed, Nafisa
Julkaistu: (2023)

Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022)

A review on triple-negative breast cancer and its potential treatment
Tekijä: Niasa, Jannatul Ferdous
Julkaistu: (2023)

Stem cells as therapeutic carrier in cancer treatment
Tekijä: Anika, Mysha Yeasmin
Julkaistu: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Tekijä: Hasan, Amit
Julkaistu: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Tekijä: Khan, Muidul Hasan
Julkaistu: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
Tekijä: Roy, Hredita
Julkaistu: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
Tekijä: Emon, Kamrul Hasan
Julkaistu: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
Tekijä: Mirza, Maisa Tasnim
Julkaistu: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
Tekijä: Khan, Rezia Nowrin
Julkaistu: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
Tekijä: Nuha, Nabiha Tahsin
Julkaistu: (2024)

Role of statins as antagonists of SPARC in gastric cancer
Tekijä: Shahmat, Rad
Julkaistu: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
Tekijä: Sorno, Rubina Haque
Julkaistu: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Tekijä: Ratu, Tabassum
Julkaistu: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
Tekijä: Choki, Kinley
Julkaistu: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Tekijä: Razna, Amrin Islam
Julkaistu: (2019)

A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
Tekijä: Mahaleka, Aarshi
Julkaistu: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Tekijä: Shaikat, Mahdi Mubin
Julkaistu: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Tekijä: Hasan, Sakib
Julkaistu: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
Tekijä: Nawar, Anika
Julkaistu: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
Tekijä: Deeba, Maliha Tasnim
Julkaistu: (2018)

Targeting BRAFV600E in the treatment of CRC
Tekijä: Roja, Mashwiyat Samrin
Julkaistu: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
Tekijä: Alam, Kazi Tasnuva
Julkaistu: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Tekijä: Rahman, Sanjida
Julkaistu: (2024)

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
Tekijä: Khondokar, Faiza
Julkaistu: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Tekijä: Islam, Nahidul
Julkaistu: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
Tekijä: Beruni, Sajid Mahmud Al
Julkaistu: (2022)

Oncogenes: new targets in cancer treatment
Tekijä: Chowdhury, Waseka Shams
Julkaistu: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
Tekijä: Muntaha, Habibatul
Julkaistu: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Tekijä: Haque, Mushfiqul
Julkaistu: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Tekijä: Karim, Samia Binte
Julkaistu: (2024)